APO Research
Talk to an analyst

APO RESEARCH · REPORT

Total Intravenous Anesthesia (TIVA)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Total Intravenous Anesthesia (TIVA) Market Outlook and Growth Opportunities 2026

19 December 2025196 pages

Choose your research edition.

Industry ResearchTotal Intravenous Anesthesia (TIVA) Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Total Intravenous Anesthesia (TIVA) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Total Intravenous Anesthesia (TIVA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Total Intravenous Anesthesia (TIVA) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Total Intravenous Anesthesia (TIVA) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Total Intravenous Anesthesia (TIVA) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Total Intravenous Anesthesia (TIVA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Total Intravenous Anesthesia (TIVA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Total Intravenous Anesthesia (TIVA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Total Intravenous Anesthesia (TIVA) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Total Intravenous Anesthesia (TIVA) market include Mylan, Hengrui, B. Braun Medical, AbbVie, Astrazeneca, Piramal, Nhwa, Maruishi and Lunan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Total Intravenous Anesthesia (TIVA) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Total Intravenous Anesthesia (TIVA) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Total Intravenous Anesthesia (TIVA) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Total Intravenous Anesthesia (TIVA) market size, projected growth trends, production technologies, key applications, and end-use industries.

Total Intravenous Anesthesia (TIVA) Segment by Company

Mylan

Hengrui

B. Braun Medical

AbbVie

Astrazeneca

Piramal

Nhwa

Maruishi

Lunan

Hikma Pharmaceuticals

Fresenius-Kabi

Baxter Healthcare

Total Intravenous Anesthesia (TIVA) Segment by Type

Barbiturates

Propofol

Midazolam

Etomidate

Others

Total Intravenous Anesthesia (TIVA) Segment by Application

Orthopedic

Cosmetic Surgeries

Predominantly Emergency

Others

Total Intravenous Anesthesia (TIVA) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Total Intravenous Anesthesia (TIVA) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Total Intravenous Anesthesia (TIVA) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Total Intravenous Anesthesia (TIVA) significant trends, drivers, influence factors in global and regions.

6. To analyze Total Intravenous Anesthesia (TIVA) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Total Intravenous Anesthesia (TIVA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Total Intravenous Anesthesia (TIVA) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Total Intravenous Anesthesia (TIVA).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Total Intravenous Anesthesia (TIVA) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Total Intravenous Anesthesia (TIVA) industry.

Chapter 3: Detailed analysis of Total Intravenous Anesthesia (TIVA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Total Intravenous Anesthesia (TIVA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Total Intravenous Anesthesia (TIVA) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Total Intravenous Anesthesia (TIVA) Industry Trends Table 2. Total Intravenous Anesthesia (TIVA) Industry Drivers Table 3. Total Intravenous Anesthesia (TIVA) Industry Opportunities and Challenges Table 4. Total Intravenous Anesthesia (TIVA) Industry Restraints Table 5. Global Total Intravenous Anesthesia (TIVA) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Total Intravenous Anesthesia (TIVA) Revenue Share by Company (2021-2026) Table 7. Global Total Intravenous Anesthesia (TIVA) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Total Intravenous Anesthesia (TIVA) Sales Volume Share by Company (2021-2026) Table 9. Global Total Intravenous Anesthesia (TIVA) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Total Intravenous Anesthesia (TIVA) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Total Intravenous Anesthesia (TIVA) Key Company Manufacturing Base & Headquarters Table 12. Global Total Intravenous Anesthesia (TIVA) Company, Product Type & Application Table 13. Global Total Intravenous Anesthesia (TIVA) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Total Intravenous Anesthesia (TIVA) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Barbiturates Table 18. Significant Companies of Propofol Table 19. Significant Companies of Midazolam Table 20. Significant Companies of Etomidate Table 21. Significant Companies of Others Table 22. Global Total Intravenous Anesthesia (TIVA) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Total Intravenous Anesthesia (TIVA) Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Total Intravenous Anesthesia (TIVA) Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Total Intravenous Anesthesia (TIVA) Sales Volume Share by Type (2021-2026) Table 26. Global Total Intravenous Anesthesia (TIVA) Sales Volume Share by Type (2027-2032) Table 27. Global Total Intravenous Anesthesia (TIVA) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Total Intravenous Anesthesia (TIVA) Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Total Intravenous Anesthesia (TIVA) Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Total Intravenous Anesthesia (TIVA) Sales Value Share by Type (2021-2026) Table 31. Global Total Intravenous Anesthesia (TIVA) Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Orthopedic Table 33. Significant Companies of Cosmetic Surgeries Table 34. Significant Companies of Predominantly Emergency Table 35. Significant Companies of Others Table 36. Global Total Intravenous Anesthesia (TIVA) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Total Intravenous Anesthesia (TIVA) Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Total Intravenous Anesthesia (TIVA) Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Total Intravenous Anesthesia (TIVA) Sales Volume Share by Application (2021-2026) Table 40. Global Total Intravenous Anesthesia (TIVA) Sales Volume Share by Application (2027-2032) Table 41. Global Total Intravenous Anesthesia (TIVA) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Total Intravenous Anesthesia (TIVA) Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Total Intravenous Anesthesia (TIVA) Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Total Intravenous Anesthesia (TIVA) Sales Value Share by Application (2021-2026) Table 45. Global Total Intravenous Anesthesia (TIVA) Sales Value Share by Application (2027-2032) Table 46. Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Total Intravenous Anesthesia (TIVA) Sales by Region (2021-2026) & (K Units) Table 48. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2021-2026) Table 49. Global Total Intravenous Anesthesia (TIVA) Sales by Region (2027-2032) & (K Units) Table 50. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2027-2032) Table 51. Global Total Intravenous Anesthesia (TIVA) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Total Intravenous Anesthesia (TIVA) Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Total Intravenous Anesthesia (TIVA) Sales Value Share by Region (2021-2026) Table 54. Global Total Intravenous Anesthesia (TIVA) Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Total Intravenous Anesthesia (TIVA) Sales Value Share by Region (2027-2032) Table 56. Global Total Intravenous Anesthesia (TIVA) Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Total Intravenous Anesthesia (TIVA) Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Total Intravenous Anesthesia (TIVA) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Total Intravenous Anesthesia (TIVA) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2026) & (K Units) Table 61. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2021-2026) Table 62. Global Total Intravenous Anesthesia (TIVA) Sales by Country (2027-2032) & (K Units) Table 63. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2027-2032) Table 64. Global Total Intravenous Anesthesia (TIVA) Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Total Intravenous Anesthesia (TIVA) Sales Value Market Share by Country (2021-2026) Table 66. Global Total Intravenous Anesthesia (TIVA) Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Total Intravenous Anesthesia (TIVA) Sales Value Market Share by Country (2027-2032) Table 68. Mylan Company Information Table 69. Mylan Business Overview Table 70. Mylan Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Mylan Total Intravenous Anesthesia (TIVA) Product Portfolio Table 72. Mylan Recent Development Table 73. Hengrui Company Information Table 74. Hengrui Business Overview Table 75. Hengrui Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hengrui Total Intravenous Anesthesia (TIVA) Product Portfolio Table 77. Hengrui Recent Development Table 78. B. Braun Medical Company Information Table 79. B. Braun Medical Business Overview Table 80. B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Portfolio Table 82. B. Braun Medical Recent Development Table 83. AbbVie Company Information Table 84. AbbVie Business Overview Table 85. AbbVie Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. AbbVie Total Intravenous Anesthesia (TIVA) Product Portfolio Table 87. AbbVie Recent Development Table 88. Astrazeneca Company Information Table 89. Astrazeneca Business Overview Table 90. Astrazeneca Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Astrazeneca Total Intravenous Anesthesia (TIVA) Product Portfolio Table 92. Astrazeneca Recent Development Table 93. Piramal Company Information Table 94. Piramal Business Overview Table 95. Piramal Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Piramal Total Intravenous Anesthesia (TIVA) Product Portfolio Table 97. Piramal Recent Development Table 98. Nhwa Company Information Table 99. Nhwa Business Overview Table 100. Nhwa Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Nhwa Total Intravenous Anesthesia (TIVA) Product Portfolio Table 102. Nhwa Recent Development Table 103. Maruishi Company Information Table 104. Maruishi Business Overview Table 105. Maruishi Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Maruishi Total Intravenous Anesthesia (TIVA) Product Portfolio Table 107. Maruishi Recent Development Table 108. Lunan Company Information Table 109. Lunan Business Overview Table 110. Lunan Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Lunan Total Intravenous Anesthesia (TIVA) Product Portfolio Table 112. Lunan Recent Development Table 113. Hikma Pharmaceuticals Company Information Table 114. Hikma Pharmaceuticals Business Overview Table 115. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Portfolio Table 117. Hikma Pharmaceuticals Recent Development Table 118. Fresenius-Kabi Company Information Table 119. Fresenius-Kabi Business Overview Table 120. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Portfolio Table 122. Fresenius-Kabi Recent Development Table 123. Baxter Healthcare Company Information Table 124. Baxter Healthcare Business Overview Table 125. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Portfolio Table 127. Baxter Healthcare Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Total Intravenous Anesthesia (TIVA) Distributors List Table 131. Total Intravenous Anesthesia (TIVA) Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Total Intravenous Anesthesia (TIVA) Product Image Figure 2. Global Total Intravenous Anesthesia (TIVA) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Total Intravenous Anesthesia (TIVA) Sales (2021-2032) & (K Units) Figure 5. Global Total Intravenous Anesthesia (TIVA) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Total Intravenous Anesthesia (TIVA) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Barbiturates Image Figure 10. Propofol Image Figure 11. Midazolam Image Figure 12. Etomidate Image Figure 13. Others Image Figure 14. Global Total Intravenous Anesthesia (TIVA) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Total Intravenous Anesthesia (TIVA) Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Total Intravenous Anesthesia (TIVA) Sales Volume Share by Type (2021-2032) Figure 17. Global Total Intravenous Anesthesia (TIVA) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Total Intravenous Anesthesia (TIVA) Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Total Intravenous Anesthesia (TIVA) Sales Value Share by Type (2021-2032) Figure 20. Orthopedic Image Figure 21. Cosmetic Surgeries Image Figure 22. Predominantly Emergency Image Figure 23. Others Image Figure 24. Global Total Intravenous Anesthesia (TIVA) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Total Intravenous Anesthesia (TIVA) Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Total Intravenous Anesthesia (TIVA) Sales Volume Share by Application (2021-2032) Figure 27. Global Total Intravenous Anesthesia (TIVA) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Total Intravenous Anesthesia (TIVA) Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Total Intravenous Anesthesia (TIVA) Sales Value Share by Application (2021-2032) Figure 30. Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Total Intravenous Anesthesia (TIVA) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Total Intravenous Anesthesia (TIVA) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032) & (US$ Million) Figure 35. North America Total Intravenous Anesthesia (TIVA) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Total Intravenous Anesthesia (TIVA) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Total Intravenous Anesthesia (TIVA) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032) & (US$ Million) Figure 41. South America Total Intravenous Anesthesia (TIVA) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Total Intravenous Anesthesia (TIVA) Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Total Intravenous Anesthesia (TIVA) Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Barbiturates
  • Propofol
  • Midazolam
  • Etomidate
  • Others
Applications
  • Orthopedic
  • Cosmetic Surgeries
  • Predominantly Emergency
  • Others
Companies covered
  • Mylan
  • Hengrui
  • B. Braun Medical
  • AbbVie
  • Astrazeneca
  • Piramal
  • Nhwa
  • Maruishi
  • Lunan
  • Hikma Pharmaceuticals
  • Fresenius-Kabi
  • Baxter Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032)
  4. 1.2.2 Global Total Intravenous Anesthesia (TIVA) Sales Volume (2021-2032)
  5. 1.2.3 Global Total Intravenous Anesthesia (TIVA) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Total Intravenous Anesthesia (TIVA) Market Dynamics
  1. 2.1 Total Intravenous Anesthesia (TIVA) Industry Trends
  2. 2.2 Total Intravenous Anesthesia (TIVA) Industry Drivers
  3. 2.3 Total Intravenous Anesthesia (TIVA) Industry Opportunities and Challenges
  4. 2.4 Total Intravenous Anesthesia (TIVA) Industry Restraints
3 Total Intravenous Anesthesia (TIVA) Market by Company
  1. 3.1 Global Total Intravenous Anesthesia (TIVA) Company Revenue Ranking in 2025
  2. 3.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Company (2021-2026)
  3. 3.3 Global Total Intravenous Anesthesia (TIVA) Sales Volume by Company (2021-2026)
  4. 3.4 Global Total Intravenous Anesthesia (TIVA) Average Price by Company (2021-2026)
  5. 3.5 Global Total Intravenous Anesthesia (TIVA) Company Ranking (2024-2026)
  6. 3.6 Global Total Intravenous Anesthesia (TIVA) Company Manufacturing Base and Headquarters
  7. 3.7 Global Total Intravenous Anesthesia (TIVA) Company Product Type and Application
  8. 3.8 Global Total Intravenous Anesthesia (TIVA) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Total Intravenous Anesthesia (TIVA) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Total Intravenous Anesthesia (TIVA) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Total Intravenous Anesthesia (TIVA) Market by Type
  1. 4.1 Total Intravenous Anesthesia (TIVA) Type Introduction
  2. 4.1.1 Barbiturates
  3. 4.1.2 Propofol
  4. 4.1.3 Midazolam
  5. 4.1.4 Etomidate
  6. 4.1.5 Others
  7. 4.2 Global Total Intravenous Anesthesia (TIVA) Sales Volume by Type
  8. 4.2.1 Global Total Intravenous Anesthesia (TIVA) Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Total Intravenous Anesthesia (TIVA) Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Total Intravenous Anesthesia (TIVA) Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Total Intravenous Anesthesia (TIVA) Sales Value by Type
  12. 4.3.1 Global Total Intravenous Anesthesia (TIVA) Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Total Intravenous Anesthesia (TIVA) Sales Value by Type (2021-2032)
  14. 4.3.3 Global Total Intravenous Anesthesia (TIVA) Sales Value Share by Type (2021-2032)
5 Total Intravenous Anesthesia (TIVA) Market by Application
  1. 5.1 Total Intravenous Anesthesia (TIVA) Application Introduction
  2. 5.1.1 Orthopedic
  3. 5.1.2 Cosmetic Surgeries
  4. 5.1.3 Predominantly Emergency
  5. 5.1.4 Others
  6. 5.2 Global Total Intravenous Anesthesia (TIVA) Sales Volume by Application
  7. 5.2.1 Global Total Intravenous Anesthesia (TIVA) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Total Intravenous Anesthesia (TIVA) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Total Intravenous Anesthesia (TIVA) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Total Intravenous Anesthesia (TIVA) Sales Value by Application
  11. 5.3.1 Global Total Intravenous Anesthesia (TIVA) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Total Intravenous Anesthesia (TIVA) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Total Intravenous Anesthesia (TIVA) Sales Value Share by Application (2021-2032)
6 Total Intravenous Anesthesia (TIVA) Regional Sales and Value Analysis
  1. 6.1 Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Total Intravenous Anesthesia (TIVA) Sales by Region (2021-2032)
  3. 6.2.1 Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2021-2026
  4. 6.2.2 Global Total Intravenous Anesthesia (TIVA) Sales by Region (2027-2032)
  5. 6.3 Global Total Intravenous Anesthesia (TIVA) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Total Intravenous Anesthesia (TIVA) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Total Intravenous Anesthesia (TIVA) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Total Intravenous Anesthesia (TIVA) Sales Value by Region (2027-2032)
  9. 6.5 Global Total Intravenous Anesthesia (TIVA) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032)
  12. 6.6.2 North America Total Intravenous Anesthesia (TIVA) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032)
  15. 6.7.2 Europe Total Intravenous Anesthesia (TIVA) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Total Intravenous Anesthesia (TIVA) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032)
  21. 6.9.2 South America Total Intravenous Anesthesia (TIVA) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Value Share by Country, 2025 VS 2032
7 Total Intravenous Anesthesia (TIVA) Country-level Sales and Value Analysis
  1. 7.1 Global Total Intravenous Anesthesia (TIVA) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Total Intravenous Anesthesia (TIVA) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2032)
  4. 7.3.1 Global Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2026)
  5. 7.3.2 Global Total Intravenous Anesthesia (TIVA) Sales by Country (2027-2032)
  6. 7.4 Global Total Intravenous Anesthesia (TIVA) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Total Intravenous Anesthesia (TIVA) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Total Intravenous Anesthesia (TIVA) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Total Intravenous Anesthesia (TIVA) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Total Intravenous Anesthesia (TIVA) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Total Intravenous Anesthesia (TIVA) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mylan
  2. 8.1.1 Mylan Company Information
  3. 8.1.2 Mylan Business Overview
  4. 8.1.3 Mylan Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Mylan Total Intravenous Anesthesia (TIVA) Product Portfolio
  6. 8.1.5 Mylan Recent Developments
  7. 8.2 Hengrui
  8. 8.2.1 Hengrui Company Information
  9. 8.2.2 Hengrui Business Overview
  10. 8.2.3 Hengrui Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hengrui Total Intravenous Anesthesia (TIVA) Product Portfolio
  12. 8.2.5 Hengrui Recent Developments
  13. 8.3 B. Braun Medical
  14. 8.3.1 B. Braun Medical Company Information
  15. 8.3.2 B. Braun Medical Business Overview
  16. 8.3.3 B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Portfolio
  18. 8.3.5 B. Braun Medical Recent Developments
  19. 8.4 AbbVie
  20. 8.4.1 AbbVie Company Information
  21. 8.4.2 AbbVie Business Overview
  22. 8.4.3 AbbVie Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AbbVie Total Intravenous Anesthesia (TIVA) Product Portfolio
  24. 8.4.5 AbbVie Recent Developments
  25. 8.5 Astrazeneca
  26. 8.5.1 Astrazeneca Company Information
  27. 8.5.2 Astrazeneca Business Overview
  28. 8.5.3 Astrazeneca Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Astrazeneca Total Intravenous Anesthesia (TIVA) Product Portfolio
  30. 8.5.5 Astrazeneca Recent Developments
  31. 8.6 Piramal
  32. 8.6.1 Piramal Company Information
  33. 8.6.2 Piramal Business Overview
  34. 8.6.3 Piramal Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Piramal Total Intravenous Anesthesia (TIVA) Product Portfolio
  36. 8.6.5 Piramal Recent Developments
  37. 8.7 Nhwa
  38. 8.7.1 Nhwa Company Information
  39. 8.7.2 Nhwa Business Overview
  40. 8.7.3 Nhwa Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nhwa Total Intravenous Anesthesia (TIVA) Product Portfolio
  42. 8.7.5 Nhwa Recent Developments
  43. 8.8 Maruishi
  44. 8.8.1 Maruishi Company Information
  45. 8.8.2 Maruishi Business Overview
  46. 8.8.3 Maruishi Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Maruishi Total Intravenous Anesthesia (TIVA) Product Portfolio
  48. 8.8.5 Maruishi Recent Developments
  49. 8.9 Lunan
  50. 8.9.1 Lunan Company Information
  51. 8.9.2 Lunan Business Overview
  52. 8.9.3 Lunan Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lunan Total Intravenous Anesthesia (TIVA) Product Portfolio
  54. 8.9.5 Lunan Recent Developments
  55. 8.10 Hikma Pharmaceuticals
  56. 8.10.1 Hikma Pharmaceuticals Company Information
  57. 8.10.2 Hikma Pharmaceuticals Business Overview
  58. 8.10.3 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Portfolio
  60. 8.10.5 Hikma Pharmaceuticals Recent Developments
  61. 8.11 Fresenius-Kabi
  62. 8.11.1 Fresenius-Kabi Company Information
  63. 8.11.2 Fresenius-Kabi Business Overview
  64. 8.11.3 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Portfolio
  66. 8.11.5 Fresenius-Kabi Recent Developments
  67. 8.12 Baxter Healthcare
  68. 8.12.1 Baxter Healthcare Company Information
  69. 8.12.2 Baxter Healthcare Business Overview
  70. 8.12.3 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Portfolio
  72. 8.12.5 Baxter Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Total Intravenous Anesthesia (TIVA) Value Chain Analysis
  2. 9.1.1 Total Intravenous Anesthesia (TIVA) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Total Intravenous Anesthesia (TIVA) Sales Mode & Process
  6. 9.2 Total Intravenous Anesthesia (TIVA) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Total Intravenous Anesthesia (TIVA) Distributors
  9. 9.2.3 Total Intravenous Anesthesia (TIVA) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst